Olaparib improves the quality of life for metastatic castration-resistant prostate cancer patients
1. Olaparib led to a bigger decrease in pain interference and symptomatic skeletal-related events...
Read More
Oncology
Trametinib improves progression-free survival among patients with low-grade serous ovarian carcinoma
1. The median progression-free survival for trametinib was significantly greater than that for...
Read More
Pembrolizumab improves survival outcomes in cervical cancer patients
1. Patients receiving pembrolizumab with or without platinum-based chemotherapy experienced longer...
Read More
The religious and spiritual beliefs of cancer patients may influence decision making
1. Overall, the influence of religion and spirituality on treatment decision making was both...
Read More
Venous thromboembolism rates in hospitalized children continue to rise
1. In a large retrospective study, rates of venous thromboembolism (VTE) in pediatric patients...
Read More
Cemiplimab treatment of recurrent cervical cancer is associated with longer overall survival
1. Overall survival is longer in patients treated with cemiplimab as compared to chemotherapy. 2....
Read More